(Q24236222)

English

Oral steroids for long-term use in cystic fibrosis

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Oral steroids for long-term use in cystic fibrosis (English)

0 references

0 references

2

Deborah Ashby

0 references

author name string

Katharine Cheng

series ordinal

1

0 references

Rosalind L Smyth

series ordinal

3

0 references

publication date

5 October 2011

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

21 January 2018

Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

21 January 2018

Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

21 January 2018

Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

21 January 2018

Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

21 January 2018

Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

21 January 2018

Statistical aspects of research methodology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

21 January 2018

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD000407.PUB2

0 references

PubMed publication ID

21975730

0 references

(Q24236222)

Oral steroids for long-term use in cystic fibrosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)